Versigent PLC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Versigent PLC announced a 10% increase in net sales for the first six months of 2026, driven by volume growth and improved operational performance, alongside a significant increase in cash and cash equivalents.